Aquarius Surgical Technologies Inc.
ASTI
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 80.60K | 112.40K | 130.90K | 152.30K | 153.80K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 80.60K | 112.40K | 130.90K | 152.30K | 153.80K |
| Cost of Revenue | 39.10K | 53.30K | 45.60K | 53.60K | 58.60K |
| Gross Profit | 41.50K | 59.10K | 85.30K | 98.70K | 95.20K |
| SG&A Expenses | 458.30K | 417.30K | 449.90K | 439.10K | 449.50K |
| Depreciation & Amortization | 22.00K | 22.50K | 23.00K | 22.90K | 21.10K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 519.40K | 493.10K | 518.50K | 515.60K | 529.20K |
| Operating Income | -438.90K | -380.80K | -387.70K | -363.40K | -375.40K |
| Income Before Tax | -654.80K | -616.80K | -580.10K | -555.20K | -474.10K |
| Income Tax Expenses | 5.20K | 5.20K | 5.20K | 6.70K | 1.50K |
| Earnings from Continuing Operations | -0.66 | -0.62 | -0.59 | -0.56 | -0.48 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -660.00K | -622.00K | -585.30K | -561.80K | -475.50K |
| EBIT | -438.90K | -380.80K | -387.70K | -363.40K | -375.40K |
| EBITDA | -426.70K | -368.10K | -374.50K | -350.40K | -362.60K |
| EPS Basic | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Normalized Basic EPS | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Normalized Diluted EPS | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 110.40M | 110.40M | 110.40M | 110.40M | 110.35M |
| Average Diluted Shares Outstanding | 110.40M | 110.40M | 110.40M | 110.40M | 110.35M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
